Immunological classification of renal cell carcinoma patients based on phenotypic analysis of immune check-point molecules-Reference-Cited by-同舟云学术

Immunological classification of renal cell carcinoma patients based on phenotypic analysis of immune check-point molecules

Published:2017-10-03 Issue:1 Volume:67 Page:113-125
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Kawashima Atsunari^ORCID,Kanazawa Takayuki,Goto Kumiko,Matsumoto Mitsunobu,Morimoto-Okazawa Akiko,Iwahori Kota,Ujike Takeshi,Nagahara Akira,Fujita Kazutoshi,Uemura Motohide,Nonomura Norio,Wada Hisashi

Funder

the Project for Development of Innovative Research on Cancer Therapeutics

the Practice Research for Innovative Cancer Control from the Japan Agency for Medical Research and Development, AMED

Osaka Kidney Bank

the Public Trust Surgery Research Fund

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/article/10.1007/s00262-017-2060-5/fulltext.html

Reference37 articles.

1. Massari F, Santoni M, Ciccarese C, Santini D (2015) The immunocheckpoints in modern oncology: the next 15 years. Expert Opin Biol Ther 15:917–921. doi: 10.1517/14712598.2015.1035251

2. Park HJ, Park JS, Jeong YH et al (2015) PD-1 upregulated on regulatory T cells during chronic virus infection enhances the suppression of CD8+ T cell immune response via the interaction with PD-L1 expressed on CD8+ T cells. J Immunol. 194:5801–5811. doi: 10.4049/jimmunol.1401936

3. Bromwich EJ, McArdle PA, Canna K, McMillan DC, McNicol AM, Brown M, Aitchison M (2003) The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer. Br J Cancer 89:1906–1908. doi: 10.1038/sj.bjc.6601400

4. Giraldo NA, Becht E, Pages F et al (2015) Orchestration and prognostic significance of immune checkpoints in the microenvironment of primary and metastatic renal cell cancer. Clin Cancer Res 21:3031–3040. doi: 10.1158/1078-0432.CCR-14-2926

5. Gerlinger M, Quezada SA, Peggs KS et al (2013) Ultra-deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomas. J Pathol. 231:424–432. doi: 10.1002/path.4284

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bacteria-derived DNA in serum extracellular vesicles are biomarkers for renal cell carcinoma;Heliyon;2023-09

2. Markers of local kidney cancer recurrence: A surgeon’s mistake or a pattern? Review;Urologia Journal;2022-12-14

3. Tumor-infiltrating ICOS⁺ Effector Regulatory T-Cells in Oral Squamous Cell Carcinoma as a Promising Biomarker for Prognosis and ‘Hot’ Tumor;Anticancer Research;2022-04-30

4. Emerging biomaterial-based strategies for personalized therapeutic in situ cancer vaccines;Biomaterials;2022-01

5. Development and validation of a PBRM1 ‐associated immune prognostic model for clear cell renal cell carcinoma;Cancer Medicine;2021-09-18